Delivery Order SPE2DR25D9114-SPE2DR26FMDS8
Award Date 10/22/25
Potential Completion Date 11/13/25
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $148,084.30 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 17, 2025. The delivery order calls for 3,750 units of Asparlas (5 ML vials) with a completion date of August 7, 2025. This firm fixed-price contract contains no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its small business status. The award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $148,084.30 by the Defense Logistics Agency on September 26, 2025, for the supply of 3,750 units of Asparlas (5 milliliter vials). The award carries a firm fixed-price structure with an ultimate completion date of October 20, 2025, and represents no set-aside designation. The place of performance is located in Park Ridge, Illinois, where...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $59,233.74 by the Defense Logistics Agency on September 10, 2025. The delivery order, with an ultimate completion date of October 1, 2025, calls for the supply of 3,750 units of Asparlas in 5 milliliter vials. This award was issued without a set-aside designation and represents a specific product delivery under DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $26,299.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the 5 ML vial of the pharmaceutical drug Asparlas. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program....
- The Defense Logistics Agency awarded a delivery order valued at $148,084.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas (5 ml vials). The contract is firm fixed-price with an ultimate completion date of September 23, 2025, and was awarded on September 2, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of 3,750 units of Asparlas 5 mL vials. The contract, valued at $59,233.74, is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025. This award was issued without set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal...
- The Defense Logistics Agency awarded a delivery order valued at $118,467.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 3,750 units of Asparlas 5 ml vials. The contract is firm fixed-price with an ultimate completion date of September 17, 2025. This delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion vehicle that...
- This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) for the procurement of 3,750 units of the pharmaceutical product ASPARLAS (5 mL vial). The $105,199.16 firm fixed-price delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999. This IDC, valid through November 2026, enables the DLA to issue delivery orders for a broad range of...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, with a ceiling value of $29,616.86 for the supply of 3,750 units of Asparlas 5 ML vials. Asparlas is a leukemia treatment medication, and this delivery order will be fulfilled from DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $29,616.86 delivery order is for the supply of 3,750 units of the 5 mL vial of the drug ASPARLAS, with a performance period ending on June 4, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...